You have 9 free searches left this month | for more free features.

the TKI dose reduction

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Withdrawal of Second-generation Tyrosine Kinase Inhibitors After

Recruiting
  • MMR on 12 Month
  • Guangzhou, Guangdong, China
  • +1 more
Apr 21, 2022

Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Withdrawal;Drug
  • Imatinib withdrawal
  • +2 more
  • Brno, Czechia
  • +7 more
Aug 24, 2022

Anxiety Trial (Mozart selections, Patient-preferred music selections)

Not yet recruiting
  • Anxiety
  • Mozart selections
  • Patient-preferred music selections
  • (no location specified)
Jul 20, 2023

Dose Reduction and Discontinuation With Anti-Fibrotic

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ridgefield, Connecticut
    Boehringer Ingelheim
Mar 24, 2023

Lower Back Pain Chronic, Facet Joint Arthrosis, Osteoarthritis, Spine Trial in Aarau (Intra-articular steroid injections,

Not yet recruiting
  • Lower Back Pain Chronic
  • +2 more
  • Intra-articular steroid injections
  • Low-dose radiation therapy
  • Aarau, Switzerland
    Kantonsspital Aarau
May 9, 2023

Atopic Dermatitis, Atopic Dermatitis Eczema Trial in Rotterdam (Dupilumab)

Not yet recruiting
  • Atopic Dermatitis
  • Atopic Dermatitis Eczema
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Aug 22, 2023

Atopic Dermatitis Trial (Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose)

Not yet recruiting
  • Atopic Dermatitis
  • Dupilumab - Discontinuation
  • +2 more
  • (no location specified)
Nov 2, 2023

Psoriasis Trial in Ghent (biological, procedure, other)

Completed
  • Psoriasis
  • Dose tapering of adalimumab in patients with supratheurapeutic serum trough levels
  • +4 more
  • Ghent, Belgium
    University Hospital
Jan 5, 2023

Surgery Trial in Charleston (Dose Response Curve Placebo, Dose Response Curve N-acetylcysteine 50 mg/kg, Dose Response Curve

Active, not recruiting
  • Surgery
  • Dose Response Curve Placebo
  • +5 more
  • Charleston, South Carolina
    Medical University of South Carolina
Jul 22, 2022

Breast Benign Tumor, Breast Malignant Tumor Trial in Birmingham (Standard of Care (SOC) gadolinium Breast MRI, reduced 1/4 dose

Active, not recruiting
  • Breast Benign Tumor
  • Breast Malignant Tumor
  • Standard of Care (SOC) gadolinium Breast MRI
  • reduced 1/4 dose gadolinium Breast MRI with Artificial Intelligence (AI) to aid in evaluation.
  • Birmingham, Alabama
    The Kirklin Clinic
Dec 12, 2022

Graft Vs Host Disease Trial in Puebla (Cyclophosphamide)

Enrolling by invitation
  • Graft Vs Host Disease
  • Puebla, Mexico
    Centro de Hematología y Medicina Interna
Mar 22, 2023

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Moscow, Russian Federation
    National Research Center for Hematology
Oct 1, 2020

Psoriasis Vulgaris Trial in Belgium (Venapuncture, Dried blood spot, Dose reduction)

Terminated
  • Psoriasis Vulgaris
  • Venapuncture
  • +2 more
  • Ghent, East-Flanders, Belgium
  • +6 more
Dec 19, 2022

Gadolinium-based Contrast Agent Reduction in Brain MRI (MAGNET)

Recruiting
  • Brain Diseases
  • Low-dose GBCA levels
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Mar 2, 2023

Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

Recruiting
  • Bronchial Neoplasms
  • Cologne, Germany
  • +6 more
Nov 2, 2022

Idiopathic Pulmonary Fibrosis Trial (nalbuphine ER, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • nalbuphine ER
  • Placebo
  • (no location specified)
Jul 19, 2023

Radiation Exposure, Liver Cancer Trial in Tubingen, Seoul (Contrast-enhanced liver CT scan)

Completed
  • Radiation Exposure
  • Liver Cancer
  • Contrast-enhanced liver CT scan
  • Tubingen, Germany
  • +2 more
Apr 10, 2023

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Frankfurt, Germany
    Department of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023

Rheumatoid Arthritis Trial in Belgium (Rituximab)

Not yet recruiting
  • Rheumatoid Arthritis
  • Merksem, Antwerpen, Belgium
  • +6 more
Aug 17, 2023

HIV Trial in Barcelona (Biktarvy 50 mg/200 mg/25 mg film-coated tablets)

Not yet recruiting
  • HIV Infections
  • Biktarvy 50 mg/200 mg/25 mg film-coated tablets
  • Barcelona, Spain
    Hospital Clinic i Provincial Barcelona
Oct 26, 2022

Plastic Surgery, Mammaplasty, Anti-bacterial Agents Trial in Pouso Alegre (Cephazolin, Sterile saline)

Recruiting
  • Plastic Surgery
  • +4 more
  • Pouso Alegre, MG, Brazil
    Hospital das Clinicas Samuel Libânio, Universidade do Vale do Sa
Jul 25, 2022

Brain Tumor, Brain Metastases, Brain Cancer Trial in Indianapolis, Portland (Reduced Dose SRS)

Recruiting
  • Brain Tumor
  • +2 more
  • Reduced Dose SRS
  • Indianapolis, Indiana
  • +2 more
Aug 29, 2022

Opioid Use, Pain, Marijuana Use Trial in Portland, Boston, Cambridge (Medical Marijuana, Prescription Opioid Taper Support

Recruiting
  • Opioid Use
  • +2 more
  • Medical Marijuana
  • Prescription Opioid Taper Support (POTS)
  • Portland, Maine
  • +2 more
Dec 13, 2022

Essential Hypertension Trial (Nerkardou 5 mg & Nerkardou 10 mg)

Not yet recruiting
  • Essential Hypertension
  • Nerkardou 5 mg & Nerkardou 10 mg
  • (no location specified)
May 30, 2023

Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

Not yet recruiting
  • Tyrosine Kinase Inhibitors
  • Chronic Myeloid Leukemia
  • treatment of TKI in CML
  • Poitiers, France
    Chu Poitiers
Feb 21, 2023